These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 26974375)
41. Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. Masmoudi O; Gandolfo P; Tokay T; Leprince J; Ravni A; Vaudry H; Tonon MC J Neurochem; 2005 Aug; 94(3):561-71. PubMed ID: 16033415 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Legoabe LJ; Petzer A; Petzer JP Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913 [TBL] [Abstract][Full Text] [Related]
43. Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors. Di Cianni A; Carotenuto A; Brancaccio D; Novellino E; Reubi JC; Beetschen K; Papini AM; Ginanneschi M J Med Chem; 2010 Aug; 53(16):6188-97. PubMed ID: 20666484 [TBL] [Abstract][Full Text] [Related]
44. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues. Mattern RH; Tran TA; Goodman M J Pept Sci; 1999 Apr; 5(4):161-75. PubMed ID: 10323196 [TBL] [Abstract][Full Text] [Related]
45. Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells. Seifert T; Malo M; Kokkola T; Engen K; Fridén-Saxin M; Wallén EA; Lahtela-Kakkonen M; Jarho EM; Luthman K J Med Chem; 2014 Dec; 57(23):9870-88. PubMed ID: 25383691 [TBL] [Abstract][Full Text] [Related]
46. [Recent advances in the study of structure modification of somatostatin]. Gong X; Han X; Wang DX Yao Xue Xue Bao; 2006 Nov; 41(11):1027-33. PubMed ID: 17262942 [No Abstract] [Full Text] [Related]
47. [DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting. Tatsi A; Maina T; Cescato R; Waser B; Krenning EP; de Jong M; Cordopatis P; Reubi JC; Nock BA Eur J Med Chem; 2014 Feb; 73():30-7. PubMed ID: 24378707 [TBL] [Abstract][Full Text] [Related]
48. Conformational analyses of somatostatin-related cyclic hexapeptides containing peptoid residues. Mattern RH; Tran TA; Goodman M J Med Chem; 1998 Jul; 41(15):2686-92. PubMed ID: 9667959 [TBL] [Abstract][Full Text] [Related]
49. Application of a novel design paradigm to generate general nonpeptide combinatorial templates mimicking beta-turns: synthesis of ligands for melanocortin receptors. Webb TR; Jiang L; Sviridov S; Venegas RE; Vlaskina AV; McGrath D; Tucker J; Wang J; Deschenes A; Li R J Comb Chem; 2007; 9(4):704-10. PubMed ID: 17429950 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and conformational analysis of cyclotetrapeptide mimetic beta-turn templates and validation as 3D scaffolds. Gentilucci L; Cardillo G; Tolomelli A; De Marco R; Garelli A; Spampinato S; Spartà A; Juaristi E ChemMedChem; 2009 Apr; 4(4):517-23. PubMed ID: 19226499 [TBL] [Abstract][Full Text] [Related]
51. Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors. Nikiforovich GV; Marshall GR; Achilefu S Chem Biol Drug Des; 2007 Mar; 69(3):163-9. PubMed ID: 17441902 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of 3-aminomethyl-2-aryl- 8-bromo-6-chlorochromones. Wallén EA; Dahlén K; Grøtli M; Luthman K Org Lett; 2007 Feb; 9(3):389-91. PubMed ID: 17249769 [TBL] [Abstract][Full Text] [Related]
53. Structure-activity relationships of chromone derivatives toward the mechanism of interaction with and inhibition of breast cancer resistance protein ABCG2. Winter E; Lecerf-Schmidt F; Gozzi G; Peres B; Lightbody M; Gauthier C; Ozvegy-Laczka C; Szakacs G; Sarkadi B; Creczynski-Pasa TB; Boumendjel A; Di Pietro A J Med Chem; 2013 Dec; 56(24):9849-60. PubMed ID: 24304387 [TBL] [Abstract][Full Text] [Related]